BioSpace News Archive

Two Labs, an industry-leading pharma services company, today announced that it has acquired CEEK Enterprises, a management consultancy dedicated to supporting clients in the biopharma and MedTech industries with specialized expertise in corporate development, commercial strategy, clinical development and medical affairs.

The panel discussion moderated by Lung is at The Hyatt Regency Grand Cypress in Orlando from 4:20-5:00pm. In addition, Lung will participate as a panelist at 11:10AM on ‘Addressing Social Determinants of Health: Helping Vulnerable Populations Thrive through Community Partnerships and Targeted Interventions’

Feb. 6, 2020 12:00 UTC CAMBRIDGE, Mass.--( BUSINESS WIRE )-- AVROBIO, Inc. (NASDAQ: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that the company has granted non-statutory stock options for the purchase of up to an aggregate of 91,250 shares of the company’s common stock to three new employees as inducement awards under the company’s 2019 Inducement Plan, in accordance with NASDAQ Listing R

Feb. 6, 2020 12:00 UTC Industry Veteran Brings Deep Expertise in Leading and Scaling Commercial Operations in Medical Device Companies REDWOOD CITY, Calif.--( BUSINESS WIRE )-- PROCEPT BioRobotics Corporation , a Silicon Valley surgical robotics company developing intelligent solutions to transform the field of urology, has announced the appointment of Reza Zadno, PhD, as its new president and chief executive officer. With more than three decades of leadership experience

Feb. 6, 2020 12:00 UTC DANVERS, Mass.--( BUSINESS WIRE )-- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported third quarter fiscal 2020 revenue of $221.6 million, an increase of 10% compared to revenue of $200.6 million for the same period of fiscal 2019. Operating income was $70.3 million, up 13%, compared to $62.4 million in the same period of fiscal 2019. Financial and operating highlights for the thir

Organizations are leveraging Vault RIM to keep pace with changing regulations

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2019 earnings release and conference call.

WALTHAM, Mass., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter and full year 2019 financial results on Thursday, February 20, 2020. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. EST to discuss business updates and financial results for the three- and twelve-month reporting periods ended December 31, 2019. The conference call will be accessible b

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner, announced the Company will release its fourth quarter 2019 results before the market opens on Thursday, March 5, 2020, to be followed by a conference call at 8:30 a.m. (Eastern Time)

Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) (“Liminal BioSciences” or the “Company” ), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with liver, respiratory and kidney disease, today announced that members of the management team will provide a business overview and update at the BIO CEO & Investor Conference.